Mate Fertility

Oklahoma City, Oklahoma 73112

Medical Director: Shaurin Patel, MD

Mate Fertility in Oklahoma City offers a supportive approach to fertility care under the guidance of Medical Director Dr. Shaurin Patel. The clinic specializes in core fertility services including IVF and egg freezing, providing essential treatment options for individuals and couples on their fertility journey.

When considering your options, it's helpful to know that Mate Fertility maintains verified lab accreditation, ensuring quality standards in their laboratory processes. For patients under 35, the clinic reports a live birth rate of 37.50% through their IVF program. In 2022, they completed 172 treatment cycles, reflecting their active practice in serving the Oklahoma City community.

Choosing a fertility clinic can feel overwhelming, but having clear information about success rates and credentials can help guide your decision. Mate Fertility's focus on established treatments like IVF and egg freezing means they concentrate their expertise on these fundamental fertility services, which may appeal to those seeking a straightforward approach to care.

Services Offered

IVF

In vitro fertilization — eggs are retrieved and fertilized in a lab, then transferred to the uterus.

Egg Freezing

Oocyte cryopreservation — eggs are retrieved and frozen for future use.

Success Rates

Success rates reflect live births per intended egg retrieval, as reported to the CDC for the 2022 reporting year. Rates vary based on individual patient factors.

Age GroupFresh TransfersFrozen TransfersNat'l Avg
Under 3537.50%-10.950.00%48.4%
35–37Not reportedNot reported36%
38–40Not reportedNot reported23.6%
Over 40Not reportedNot reported9.5%

Based on 172 total cycles reported. National averages computed across all reporting clinics.

Nearby Clinics

Data on this page is sourced from the CDC's National ART Surveillance System (NASS) and the Society for Assisted Reproductive Technology (SART). Success rates reflect live births per intended egg retrieval for the 2022 reporting year. Individual results vary based on patient age, diagnosis, and treatment protocol.